Breaking News

LakePharma Offers COVID-19 Proteins to Biotechs

Provides recombinant COVID-19 proteins to facilitate antibody and diagnostic development against COVID-19

By: Contract Pharma

Contract Pharma Staff

LakePharma has made various versions of recombinant COVID-19 spike proteins using rapid CHO manufacturing platforms. As a contribution towards combating the current pandemic, LakePharma is making these purified COVID-19 proteins available to the biotech community for rapid antibody and diagnostic development under relaxed business terms.   The recombinant COVID-19 spike proteins are produced using LakePharma proprietary TunaCHO manufacturing platforms. They include the full length ectodomain of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters